We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AI Tool Improves Accuracy of Skin Cancer Detection

By LabMedica International staff writers
Posted on 14 Nov 2025

Diagnosing melanoma accurately in people with darker skin remains a longstanding challenge. More...

Many existing artificial intelligence (AI) tools detect skin cancer more reliably in lighter skin tones, often missing early signs in patients with darker skin. This contributes to later-stage diagnoses and poorer outcomes. To address this diagnostic gap, researchers have developed a new AI-based method that improves skin tone recognition and enhances melanoma detection across diverse patient groups.

The collaborative research led by Fox Chase Cancer Center (Philadelphia, PA, USA) introduces a more equitable approach to training AI tools for dermatology. The researchers focused on understanding why existing AI systems underperform in darker skin tones. They found that most models are trained on narrow datasets—often sourced from limited geographic regions, hospitals, or time periods—and fail to represent the full spectrum of human skin color.

This lack of diversity leads to biased diagnostic results that favor lighter-skinned individuals. Recent imaging and AI studies have sought to enhance detection across skin types, but few have directly examined how skin color affects diagnostic performance. To overcome this limitation, the team developed MST-AI, a method based on the Monk Skin Tone (MST) scale, which uses 10 distinct shades to capture a wider range of skin tones. MST-AI estimates skin color more precisely and was tested on a large public dataset of skin cancer images.

The approach, highlighted in the Journal of Imaging, provides stronger accuracy and more reliable skin tone assignments compared with existing techniques, creating a more representative foundation for AI training. The MST-AI method helps correct skin tone imbalances in dermatology datasets, allowing AI models to learn from a more inclusive sample. This can improve early detection, reduce missed or delayed melanoma diagnoses in people of color, and support the development of fairer clinical AI tools.

“Our results show that MST-AI gives more accurate and reliable skin tone estimates than the other methods, based on trusted evaluation scores. It helps correct skin tone imbalances in large dermatology datasets, creating a better base for accurate and fair diagnosis,” said Hayan Lee, PhD, corresponding author on the study.

Related Links:
Fox Chase Cancer Center


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.